Cronos Group Investor Dashboard

Company Overview:

Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across five continents. Cronos Group operates two wholly-owned Canadian licensed producers: Peace Naturals Project Inc., which was the first non-incumbent medical cannabis license granted by Health Canada, and Original BC Ltd., which is based in the Okanagan Valley, British Columbia. Cronos Group has multiple international production and distribution platforms and partnerships across five continents. Cronos Group intends to continue to rapidly expand its global footprint as it focuses on building an international iconic brand portfolio and developing disruptive intellectual property. Cronos Group is committed to building industry leading companies that transform the perception of cannabis and responsibly elevate the consumer experience.

[stock_market_chart symbol=”CRON.TO” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]

Key Share Information:

Current Share Price$12.50
Market Capitalization (in Millions)$4,162.75
Last Quarter (Share Data)3/31/2019
Shares Outstanding (in Millions)333.02
Options (in Millions)12.83
Warrants (in Millions)21.07
Fully Diluted (in Millions)366.91

TTM Revenue$31.28
TTM Growth Margin %105.57%
TTM Operating Expenses$56.08
TTM OCF-$4.65
P/S TTM133.06
P/S (Last Quarter Run Rate)148.99

Key Balance Sheet Information (in Millions $CAD):

 CYQ4'16CYQ1'17CYQ2'17CYQ3'17CYQ4'17CYQ1'18CYQ2'18CYQ3'18CYQ4'18CYQ1'19
Cash$3.46$15.21$4.41$27.06$9.21$32.37$89.61$41.48$32.63$2,418.28
Biological Assets$1.79$2.74$2.78$2.81$3.72$4.49$6.90$5.63$9.07$11.51
Inventory$1.91$2.26$2.71$4.80$8.42$9.01$12.33$15.07$11.58$25.15
Total Assets$42.90$58.61$55.10$79.42$101.03$140.24$235.44$234.45$261.12$2,698.04
Net Tangible Assets$29.90$45.61$42.10$66.42$88.03$131.29$222.60$221.31$248.09$2,685.16
Intangibles/Goodwill$13.00$13.00$13.00$13.00$13.00$12.98$12.84$13.14$13.03$12.88
Total Liabilities$9.22$8.00$4.11$11.89$14.66$8.95$8.17$12.19$49.48$1,728.09

Key Operating Items (Quarterly in Millions $CAD):

 CYQ4'16CYQ1'17CYQ2'17CYQ3'17CYQ4'17CYQ1'18CYQ2'18CYQ3'18CYQ4'18CYQ1'19
Revenue$0.55$0.51$0.64$1.31$4.08$2.95$3.39$3.76$17.15$6.99
Change in Fair Value of Biologial Assets-$2.18-$1.81-$1.30-$3.01-$11.62-$4.46-$6.83-1.53-11.57-$13.55
Gross Margin$1.99$1.04$1.12$2.00$7.23$1.93$6.352.0911.27$13.32
Marketing and Sales$0.59$0.360.604.11$1.50
Investor Relations
Total Operating Expenses$4.36$1.93$2.61$2.06$9.34$4.11$5.866.9729.38$13.88
Operating Cash Flow (Quarterly)-$6.48-$1.93-$1.40$5.57-$7.79-$13.75$6.88-5.772.90-$8.66
Investing Cash Flow (Quarterly)-$8.01-$3.25-$0.66-$7.84-$27.02-$8.13-$22.04-5.76-85.55$116.04
Financing Cash Flow (Quarterly)$16.82$16.92-$20.49$25.21$28.43$45.04$49.23-93.83154.20$2,254.92

Listing Statement

All of the information on this dashboard was collected on a best efforts basis. This information should not be relied upon to make investment decisions. Always do your own diligence when purchasing a security and contact a licensed financial representative.

Share
Tweet
Share